Cite
HARVARD Citation
Silla, A. et al. (2021). The beneficial role of evolocumab on the vascular function of high cv risk subjects: Beyond low-density lipoprotein cholesterol lowering.. Atherosclerosis. pp. e210-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Silla, A. et al. (2021). The beneficial role of evolocumab on the vascular function of high cv risk subjects: Beyond low-density lipoprotein cholesterol lowering.. Atherosclerosis. pp. e210-. [Online].